MassChallenge is a non-equity startup accelerator headquartered in Boston, Massachusetts, with additional locations in Israel, Mexico, Switzerland, Texas, and the UK. Founded in 2009, it focuses on fostering innovation and entrepreneurship by supporting high-potential startups across various industries globally. MassChallenge provides expert mentorship, a tailored curriculum, and access to corporate partners without taking any equity from the startups. Its programs, including specialized initiatives like MassChallenge FinTech and MassChallenge HealthTech, aim to facilitate partnerships between startups and established companies to drive innovation and growth. To date, MassChallenge has helped over 1,200 alumni raise more than $2 billion in funding and create over 65,000 jobs, demonstrating its significant impact on the global innovation ecosystem.

Massachusetts Capital Resource Company, founded in 1977 and based in Boston, Massachusetts, serves as a private investment firm focused on addressing the funding gap for growing companies. The company provides risk capital in the form of mezzanine financing, long-term debt, and equity investments, specifically targeting emerging growth and middle-market firms. Its primary sectors of interest include manufacturing, distribution, service, and technology. By offering tailored investment solutions, Massachusetts Capital complements the financing available from senior lenders and equity investors, thereby supporting the growth and acquisition needs of companies operating in Massachusetts.

The National Science Foundation (NSF), established in 1950 and located in Alexandria, Virginia, is an independent federal agency dedicated to advancing fundamental research and education across all scientific and engineering disciplines. With an annual budget of approximately $7.8 billion, the NSF operates America's Seed Fund, which allocates nearly $200 million each year to support startups and small businesses through the Small Business Innovation Research (SBIR) program. This initiative provides non-dilutive funding of up to $1.5 million to assist in research and development efforts, thereby facilitating the transformation of scientific discoveries into commercially viable products and services. By helping to de-risk technology, the NSF plays a crucial role in fostering innovation and addressing societal challenges through scientific advancements.

MassVentures is a venture capital firm based in Waltham, Massachusetts, established in 1978 as a quasi-public corporation by the Massachusetts Legislature. The firm focuses on providing seed and early-stage funding to high-growth startups, facilitating their transition from concept to commercialization. MassVentures invests primarily in sectors such as information technology, healthcare, cybersecurity, e-commerce, mobile, manufacturing, and robotics. With a governance structure that includes an independent Board of Directors and management by experienced venture capitalists, MassVentures leverages the state's entrepreneurial spirit and innovation centers to support the Massachusetts innovation economy. The firm also offers accelerator programs to further assist emerging companies in their growth journey.

The U.S. Department of Energy is a government agency established in 1977, located in Washington, D.C. Its primary mission is to ensure the security and prosperity of the nation by tackling energy, environmental, and nuclear challenges. The Department focuses on promoting transformative scientific and technological solutions to address these issues, thereby supporting the country's energy needs and environmental sustainability.

Enhanced Capital Partners, founded in 1999 and headquartered in New York City, is a national investment firm specializing in equity and debt investments in small and mid-sized companies across the United States. With over $400 million under management, the firm focuses on various sectors, including healthcare technology, renewable energy, and affordable housing projects. Enhanced Capital employs a flexible investment approach that includes offering tax credits, tax credit lending, and impact lending to foster the growth and expansion of businesses. The firm manages multiple funds that primarily target the lower middle market, utilizing federal and state incentive programs along with public policy investment strategies to maximize growth potential and support rapid development for its portfolio companies.

RA Capital Management, L.P. is a Boston-based venture capital firm that specializes in early and multi-stage investments in the healthcare and life sciences sectors. Founded in 2001, the firm focuses on companies developing drugs, medical devices, diagnostics, and biotechnology. RA Capital invests in a range of funding stages, from seed funding to later rounds, and is known for its willingness to invest under $1 million in initial rounds or larger sums in established companies. The firm's investment strategy emphasizes companies with promising technologies and products, particularly in areas like prevention, cost-effective diagnostics, genetic testing, and personalized medicine. The team consists of professionals with backgrounds in biology, chemistry, and medicine, enabling them to provide valuable insights into data, regulatory processes, and market demands. Additionally, RA Capital often seeks to co-invest and take board positions in its portfolio companies, enhancing their strategic growth opportunities.

Atlas Venture is a private equity and venture capital firm based in Cambridge, Massachusetts, founded in 1980. The firm specializes in early-stage investments, particularly in the life sciences and technology sectors, with a strong emphasis on biotechnology and personalized medicine. Atlas Venture adopts a seed-led venture creation strategy, rigorously selecting opportunities to build scalable businesses. It typically invests between $0.25 million and $15 million per transaction, preferring to be a lead investor and to obtain board representation in its portfolio companies. The firm primarily focuses on startups in the United States and Europe, particularly in New England and the San Francisco Bay Area. Since its inception, Atlas Venture has managed over $2 billion in committed capital and has been involved in the creation and growth of numerous companies, with many achieving significant exits through acquisitions or public offerings. The firm has distinct teams dedicated to life sciences and technology investments, allowing for specialized attention in these dynamic fields.

Connecticut Innovations, founded in 1989 and based in New Haven, Connecticut, is a venture capital investment firm focused on high-tech industries, including energy, biotechnology, information technology, and photonics. The firm provides strategic capital and operational insight to companies at various stages of development, from seed to later stages. Its investment strategy encompasses a wide range of sectors, such as SaaS, manufacturing, life sciences, clean tech, oncology, cybersecurity, infrastructure, big data, e-commerce, and other technology-based fields. Connecticut Innovations aims to be the primary source of financing and support for innovative companies in Connecticut, offering flexible financing solutions, strategic guidance, and valuable connections to help businesses succeed and grow.

Polaris Partners is a venture capital firm founded in 1996 and headquartered in Boston, Massachusetts. With additional offices in San Francisco and New York, the firm specializes in investing across all stages of technology and healthcare companies, including life sciences and biotechnology. Polaris has established a strong track record over its more than 20 years in the industry, focusing on partnering with repeat entrepreneurs and innovators who are enhancing quality of life and work. The firm's investments are directed primarily within the United States and Europe, supporting companies from their founding stages to profitable growth.

GV Management Company, LLC, formerly known as Google Ventures, serves as the venture capital arm of Alphabet Inc., established in 2009 and headquartered in Mountain View, California, with additional offices in Boston, New York, Cambridge, and London. The firm specializes in growth capital investments across various stages, including seed, early, mid, and late stages, focusing on sectors such as life sciences, healthcare, artificial intelligence, robotics, cyber security, and agriculture. GV has invested in over 300 companies, seeking to support startups that aim to innovate and transform industries. The firm typically invests up to $50 million, with smaller amounts allocated to early-stage ventures. GV provides its portfolio companies with exceptional support by connecting them with Google's resources and talent, leveraging a team of experts in engineering, design, science, and marketing to enhance their growth potential.

General Catalyst Group Management, LLC is a private equity and venture capital firm founded in 2000 and based in Cambridge, Massachusetts, with additional offices in North America and Europe. The firm specializes in early-stage and growth equity investments, focusing on a wide range of technology sectors, including advanced materials, clean energy, disruptive technology, healthcare IT, and consumer services, among others. General Catalyst typically invests between $0.05 million and $0.25 million in seed-stage companies and between $10 million and $50 million in growth equity, seeking profitable firms with substantial revenue and EBITDA. Their approach emphasizes mentorship and collaboration, fostering strong relationships with entrepreneurs who share their vision and values. They have managed eight venture capital funds, accumulating around $3.75 billion in capital commitments, reflecting their commitment to supporting innovative companies throughout their growth journey.

Alumni Ventures Group, LLC is a venture capital firm founded in 2013 and based in Manchester, New Hampshire, with additional offices in major cities across North America. The firm specializes in seed, early-stage, and late-stage pre-IPO investments, focusing on companies with an alumni connection and supported by established institutional lead investors. Alumni Ventures aims to provide accredited investors, particularly alumni from top entrepreneurial schools, with access to diversified venture portfolios that span various sectors and geographic regions. The firm typically invests between $0.01 million and $3 million and does not require board or observer seats in its portfolio companies. Through its managed fund families, Alumni Ventures enables investors to participate in a collaborative investment approach, fostering connections among alumni while facilitating investment opportunities in innovative ventures.

5Y Capital is a private equity and venture capital firm based in Shanghai, China, focused on seed, start-up, early venture, and growth capital investments. Founded in 2008 and previously known as Morningside Venture Capital, the firm manages approximately USD 5 billion in dual-currency funds, supported by global investors such as sovereign wealth funds, family offices, and endowments. 5Y Capital primarily invests in various sectors, including healthcare, technology, fintech, media, software, life sciences, and education, with a special emphasis on medical treatment, biotechnology, and digital health. The firm seeks opportunities in China and other emerging markets across Asia and the Pacific, aiming to support entrepreneurs in building innovative companies. 5Y Capital typically makes initial investments exceeding USD 500,000 per portfolio company and operates as a subsidiary of Morningside Group, which has been active in venture capital investments since 1992.

Wellington Management Company LLP, founded in 1928 and headquartered in Boston, Massachusetts, is a prominent investment management firm providing comprehensive solutions to institutional clients worldwide. The firm specializes in a diverse range of investment strategies, including equity, fixed income, multi-asset, and alternative investments, tailored to meet the unique return and risk objectives of its clients. Wellington Management employs a collaborative approach, leveraging proprietary research and analytical tools to identify opportunities and manage risks across global capital markets. The firm caters to a wide array of clients, including sovereign institutions, endowments, foundations, wealth managers, and insurance companies, spanning more than 50 countries. With a focus on long-term investment principles, Wellington Management fosters independent thought and debate within its teams, ensuring that resources are effectively utilized to deliver consistent results. The firm also emphasizes environmental, social, and governance (ESG) considerations in its research and investment processes, engaging with companies on key ESG topics.

Flagship Pioneering, established in 2000 and based in Cambridge, Massachusetts, is a venture capital firm that focuses on creating and nurturing innovative companies in the fields of healthcare, biotechnology, life sciences, renewable energy, and agriculture. The firm emphasizes the development of first-in-category ventures designed to transform human health and promote sustainability. By combining scientific expertise with entrepreneurial leadership, Flagship Pioneering adopts an evolutionary approach to navigate from ambitious ideas to transformative outcomes. The firm is committed to attracting and cultivating top talent in science and management, positioning itself as a leader in advancing technologies that address critical global challenges.

F Prime, Inc. is a venture capital firm based in Cambridge, Massachusetts, with additional offices in San Francisco and London. Founded in 1969, it has a strong legacy rooted in Fidelity Investments, which has been a significant player in asset management since 1946. F Prime focuses on early-stage investments in North America and Europe, primarily in the healthcare, life sciences, technology, therapeutics, fashion, medtech, and health information technology sectors. The firm operates several funds, including those dedicated to healthcare, oncology, life sciences, and health technology services. F Prime Capital Partners emphasizes supporting entrepreneurs without the pressure of external fundraising, allowing them to concentrate on identifying and nurturing promising companies.

Accomplice Management LLC is a venture capital firm based in Boston, Massachusetts, with an additional office in San Francisco, California. Founded in 2015, it specializes in seed, startup, and early-stage investments primarily in technology companies. Accomplice focuses on sectors such as cybersecurity, eSports, data analytics, SMB class software, emerging hardware platforms, and marketplaces. The firm employs a community-driven investment approach, utilizing platforms like AngelList and Boston Syndicates to empower and support founders. Accomplice is recognized as one of the most active early-stage firms in New England, with a significant portion of its investments concentrated in Boston, while also extending its reach throughout the U.S., Canada, and Europe. The firm was previously known as Atlas Venture before separating its technology and life sciences divisions in 2014.

OrbiMed Advisors LLC is a healthcare-focused investment firm founded in 1989, headquartered in New York City, with additional offices in various global locations. The firm manages approximately $5 billion in assets and specializes in private equity and venture capital investments across the healthcare sector, including pharmaceuticals, biotechnology, medical devices, and healthcare services. OrbiMed invests in companies at various stages, from early startups to established multinationals, and typically seeks to take majority stakes in its private equity investments. The firm employs fundamental analysis to guide its investment decisions and offers a range of financial services, including debt financing and structured capital, to both public and private healthcare companies. OrbiMed's investment strategy encompasses a broad spectrum of healthcare-related opportunities, targeting investments globally, primarily in North America, Europe, and Asia.

The Invus Group is a private equity firm based in New York, founded in 1985. It specializes in making direct and indirect investments in various stages of companies, focusing on special situations, venture capital, and growth equity. The firm manages an evergreen fund, which allows it significant flexibility in investment strategies and the types of companies it engages with, including those in consumer products, food, specialty retail, software, biotech, and medical devices. Invus emphasizes a tailored approach to each investment, recognizing the uniqueness of every business and the need for long-term commitment to foster transformation. The firm aligns its incentives with those of its partners and has a history of empowering owner-managers by reinvesting capital from a consistent group of European families. Invus operates from offices in New York, London, Paris, and Hong Kong and manages assets exceeding $4 billion.

The Massachusetts Life Sciences Center (MLSC) is a quasi-public agency dedicated to fostering innovation within the life sciences sector in Massachusetts. Established under the Massachusetts Life Sciences Act, the Center's mission is to create jobs and enhance scientific research that benefits public health. It provides financial support to both public and private entities engaged in life sciences research, development, and commercialization, focusing on areas such as biopharma, medical devices, diagnostics, and digital health. The MLSC operates an Accelerator Loan Program aimed at offering working capital to early-stage life sciences companies with strong potential for growth and technology commercialization. Through these initiatives, the Center aims to strengthen the ties within the Massachusetts life sciences community and promote economic development driven by innovation.

New Enterprise Associates, Inc. is a global venture capital and private equity firm based in Menlo Park, California, founded in 1977. The firm specializes in investments across various stages of company development, from seed and startup to later-stage growth and public investments. With over $19 billion in cumulative committed capital, NEA focuses on technology and healthcare sectors, particularly in areas such as consumer internet, financial technology, software, healthcare services, life sciences, and energy technology. The firm also invests in semiconductor companies and alternative energy initiatives in India. NEA has a proven track record, with more than 210 portfolio company IPOs and over 360 acquisitions. The firm's investment strategy encompasses a global perspective, targeting opportunities in North America, Asia, and South America, and typically involves investments ranging from $0.05 million to $20 million.

Perceptive Advisors LLC is an investment management firm founded in 1999 and headquartered in New York City, with an additional office in Boston. The firm specializes in the healthcare sector, focusing on biotechnology, pharmaceuticals, life sciences, diagnostics, digital health, medical devices, and healthcare services. It engages in venture capital and incubation, investing at various stages of a company's life cycle, including seed and Series A funding, as well as late-stage venture and public market investments. Perceptive Advisors employs a long/short equity strategy and utilizes hedging techniques, including equity options and index options, while conducting in-house research to inform investment decisions. The firm also manages separate client-focused equity portfolios and provides customized debt financing solutions through its Perceptive Credit Opportunities Fund. Its clientele includes institutional investors, financial institutions, investment funds, and high-net-worth individuals.

Matrix Partners is a venture capital firm established in 1977, with offices in San Francisco, Cambridge, Shanghai, Beijing, Mumbai, and Bangalore. The firm focuses on seed, early-stage, late-stage, and growth capital investments across various sectors, including software, communications, artificial intelligence, fintech, digital health, and clean technology. With a commitment to building long-term relationships with entrepreneurs, Matrix Partners aims to support visionary founders in developing significant, industry-leading companies. The firm has a strong track record, having participated in hundreds of investments, with many of its portfolio companies achieving successful IPOs or profitable mergers and acquisitions. The team at Matrix Partners combines local insights with global expertise, comprising both former entrepreneurs and seasoned investors.

ARCH Venture Partners is a private equity and venture capital firm founded in 1986 and based in Chicago, Illinois. It specializes in investing in early-stage and later-stage technology companies, primarily focusing on life sciences, biotechnology, advanced materials, and various tech sectors such as clean technology, software, and communications. The firm is recognized for its role in commercializing innovations developed at academic research institutions and national laboratories. ARCH typically begins with conservative seed investments to mitigate risk, later leading or co-leading funding rounds up to liquidity. With a national scope and a regional focus, it targets underserved geographic markets and seeks to invest in companies addressing neurodegenerative diseases and mental health issues. ARCH has raised over $3 billion through ten venture funds and has invested in more than 150 companies, with a preference for co-founding partnerships with leading scientists and entrepreneurs. Its investors include major corporations, pension funds, and private investors.

Slater Technology Fund is a venture capital firm founded in 1997 and based in Providence, Rhode Island. The firm specializes in investing in early-stage and seed-stage companies, with a focus on life sciences, biomedical technology, information technology, and clean energy. Within these sectors, it targets software, internet, digital media, and technologies related to energy and the environment. Slater Technology Fund primarily invests in companies located in Rhode Island and the Northeast United States, often supporting ventures that emerge from local academic institutions and government research laboratories. The fund typically invests up to $0.75 million per transaction and can allocate up to $3 million annually. Investments are made with the expectation of substantial follow-on financing from other venture capital firms or strategic partners, aiming to foster the growth of high-value, high-wage jobs in the region.

Founded in 2009, Founder Collective is a venture capital firm with headquarters in Cambridge, Massachusetts, and an additional office in New York City. The firm specializes in seed-stage investments, primarily targeting technology-related companies across the United States. It is a Registered Investment Adviser and manages approximately $50 million in assets. Founder Collective operates several funds, including early-stage venture capital funds co-managed with Koa Labs. While the firm is open to various industries, it shows a preference for investments with an information technology component. The firm's approach is driven by a team of successful entrepreneurs who leverage their expertise to identify promising opportunities in the technology sector.

Bessemer Venture Partners is a prominent venture capital firm, founded in 1911 and based in Redwood City, California. With approximately $4 billion in assets under management, the firm invests globally in startups across various sectors, including consumer, enterprise, healthcare, information technology, and deep tech, from seed stage to growth. Bessemer's partners are dedicated to supporting founders by providing guidance and resources throughout the company's lifecycle. The firm has a notable track record of backing early-stage investments in companies such as Pinterest, Skype, and Twitch, and has played a significant role in the development of 117 IPOs, including notable names like Twilio and LinkedIn. With funds targeting a range of sectors, Bessemer Venture Partners exemplifies a commitment to fostering innovation and building enduring businesses.

Insight Partners is a global private equity and venture capital firm founded in 1995 and headquartered in New York City, with additional offices in London, Tel Aviv, and Palo Alto. The firm specializes in investing in growth-stage technology, software, and internet companies, focusing on sectors such as B2B, B2C, cybersecurity, cloud technology, and financial technology. With over $75 billion in assets under management, Insight Partners has invested in more than 750 companies worldwide, helping many achieve significant milestones, including over 55 initial public offerings. The firm’s approach emphasizes hands-on collaboration with visionary executives, providing practical expertise to support companies throughout their growth journey. Insight Partners is committed to fostering a culture that views growth as an opportunity, driving transformative change across various industries.

The Engine is a venture capital firm based in Cambridge, Massachusetts, founded in 2016 by the Massachusetts Institute of Technology (MIT). It focuses on early-stage investments in companies that leverage breakthrough science and engineering to address significant global challenges. The firm provides a supportive infrastructure, including physical space and access to specialized resources, to help startups develop their ideas and bring them to market. The Engine aims to expedite the transition from concept to impact by connecting entrepreneurs with patient capital and offering essential business support, including planning and legal assistance. It targets various sectors, such as advanced manufacturing, energy, biotech, and artificial intelligence, and seeks to maintain lower equity stakes to allow founders greater control over their ventures. By fostering a collaborative environment, The Engine supports up to 60 startups simultaneously, enabling them to thrive in a nurturing ecosystem.

.406 Ventures, LLC is a Boston-based venture capital firm founded in 2005 that specializes in early-stage investments, primarily focusing on enterprise IT companies. The firm targets sectors such as information technology security, cyber security, digital health, cloud technology, and financial technology, among others. .406 Ventures typically invests between $2 million and $5 million initially, with total investments ranging from $6 million to $10 million per company. It seeks to be the lead institutional investor and often acquires significant stakes, ranging from 20% to 80%, in its portfolio companies. The firm emphasizes its involvement in technology-enabled business services and next-generation software, particularly those employing innovative delivery models. With a strong emphasis on building value through industry expertise and networks, .406 Ventures also reserves capital for opportunistic investments in more mature companies where technology shifts present growth opportunities.

Alexandria Venture Investments, LLC is a venture capital firm established in 1996 and headquartered in Pasadena, California. As the strategic investment arm of Alexandria Real Estate Equities, it focuses on providing capital to seed, early-stage, and growth-stage companies within the healthcare sector. The firm emphasizes investments in biopharma, diagnostics, life sciences, research tools, agrifoodtech, and agtech. Alexandria Venture Investments aims to support innovative entities developing breakthrough technologies and therapies, leveraging its extensive industry knowledge and relationships with leading investors. Its approach is characterized by a commitment to fostering innovation and entrepreneurship in the life sciences and technology sectors.

Flybridge is a venture capital firm headquartered in Boston, Massachusetts, focused on seed and early-stage investments in the technology sector. Established in 2002, the firm primarily invests in companies involved in computer hardware, software, SaaS, and big data. In addition to its investment activities, Flybridge also provides support and resources for the growth and development of various businesses through internet media and marketing services. These services include advertising, software development, web design, and consulting, enabling companies to enhance their online presence and connect with customers effectively. By leveraging its expertise and network, Flybridge aims to foster innovation and help entrepreneurs succeed in their endeavors.

North Bridge Venture Partners, founded in 1994 and based in Wellesley, Massachusetts, is a venture capital firm that focuses on providing seed, early-stage, and growth-stage funding to U.S. companies. The firm specializes in various sectors, including healthcare, software, communications, infrastructure, digital media, and material production. North Bridge is committed to investing in talented individuals whose innovative ideas have the potential to significantly impact their industries. By offering financial support and expertise, the firm aims to help transform these ideas into successful companies and to establish them as market leaders. North Bridge is also a Registered Investment Adviser, emphasizing its dedication to responsible investment practices.

Fidelity Investments, founded in 1946 and headquartered in Boston, Massachusetts, is a privately owned investment management firm that offers a wide range of financial services. These services include individual retirement accounts (IRAs), 401(k) rollovers, annuities, discount brokerage, retirement planning, estate planning, wealth management, and life insurance. The firm caters to individual investors, businesses, financial advisors, and institutions, managing equity, fixed income, and balanced mutual funds. Fidelity invests in global public equity and fixed income markets, employing in-house research to inform its investment decisions. The firm serves over 32 million individuals, assists more than 22,000 businesses in managing employee benefits, and provides support to over 13,000 financial institutions with innovative solutions. Fidelity operates through numerous regional offices and Investor Centers across the United States.

Pillar is a venture capital firm based in Boston, established in 2016, that focuses on early-stage investments in technology-driven companies. The firm partners with founders from the inception of their ideas, providing initial capital and supporting their growth through connections, coaching, and community engagement. Pillar is particularly interested in high-potential ventures across various sectors, including machine intelligence, artificial intelligence, hardware, enterprise software, blockchain, digital health, and synthetic biology. The firm aims to back both first-time and experienced entrepreneurs, fostering the development of the next generation of impactful companies in the region.

M&T Charitable Foundation is a 501(c)(3) not-for-profit charitable organization. The M&T Charitable Foundation strives to strengthen communities by providing support for a diverse range of civic, cultural, health and human service organizations through grants, employee volunteerism and in-kind services.

Khosla Ventures is a venture capital firm established in 2004 by Vinod Khosla, co-founder of Sun Microsystems, and is headquartered in Menlo Park, California. The firm manages over $5 billion and focuses on investing in a diverse range of sectors, including consumer technology, enterprise solutions, education, healthcare, financial services, agriculture, sustainable energy, and robotics. Khosla Ventures provides not only capital but also strategic guidance to entrepreneurs, particularly in early-stage ventures, where it often supports innovative and unconventional projects. The firm seeks to back companies that are driven by breakthrough technologies, with investment sizes ranging from $100,000 to over $20 million. Khosla Ventures maintains a collaborative approach, frequently co-investing with other firms, including Kleiner Perkins, with which it has historical ties.

Mission BioCapital is a venture capital firm based in Cambridge, Massachusetts, specializing in investments in early-stage life science and biotechnology companies. Founded in 2009, the firm is recognized for its leadership team's extensive experience in investing in and launching numerous life science ventures. Mission BioCapital operates in regions known for their strong research and venture capital ecosystems, allowing it to leverage local expertise and networks. The firm is committed to providing comprehensive support to its portfolio companies, earning a reputation for its deep engagement and strategic guidance in the life sciences sector.

SOSV is a global venture capital firm founded in 1995 and headquartered in Princeton, New Jersey. Specializing in seed-to-growth stage investments, SOSV operates multiple accelerator programs worldwide, including HAX for hardware, IndieBio and RebelBio for life sciences, Chinaccelerator and MOX for cross-border internet ventures, Food-X for innovative food solutions, and dlab for blockchain technology. The firm focuses on investments in revolutionary deep technologies aimed at improving human and planetary health, as well as cross-border markets, particularly in Asia. SOSV invests in approximately 150 startups annually, providing support through its resources to accelerate product development and scaling. Over its two-decade history, SOSV has established a strong reputation, consistently ranking among the top venture capital firms globally.

Casdin Capital, LLC is a New York-based investment firm established in 2012, specializing in the life sciences and healthcare sectors. The firm focuses on venture capital investments across various areas, including oncology, digital health, agtech, and broader healthcare. It operates as a Registered Investment Adviser and manages a long-short equity fund. Casdin Capital engages in both early-stage and late-stage private investments, utilizing a fundamental research approach to identify promising opportunities in its target industries. As of October 2020, the firm manages approximately $2.2 billion in assets. The founder and Chief Investment Officer, Eli Casdin, has been instrumental in shaping the firm’s investment strategy and direction.

Osage Partners LLC is a private equity and venture capital firm based in Bala Cynwyd, Pennsylvania, with additional offices in Princeton, New Jersey. Founded in 1990, it specializes in investing in early-stage, startup, and late-stage companies primarily in the technology and healthcare sectors. Osage Partners focuses on a diverse range of industries, including business-to-business software, life sciences, healthcare information technology, medical devices, data analytics, cybersecurity, and advanced materials. The firm typically invests between $1 million and $4 million in companies with annual revenues ranging from $500,000 to $3 million, emphasizing those that are commercializing university technologies. Osage Partners actively engages with its portfolio companies by leading or co-leading investment rounds and participating on corporate boards and governance committees. It concentrates its investments in the East Coast and Mid-Atlantic regions of the United States, broadly defined as the area from Washington, D.C., to New York and Pittsburgh. The firm is also known for its collaboration with over 80 research universities to support innovative startups.

Bain Capital is a prominent private equity firm based in Boston, Massachusetts, founded in 1984. It specializes in various investment strategies, including private equity, venture capital, credit products, and real estate, managing over $95 billion in assets. The firm focuses on a diverse range of sectors such as healthcare, technology, consumer products, and manufacturing. Bain Capital operates through several specialized units, including Bain Capital Double Impact, which emphasizes impact investing in sustainability and social good, and Bain Capital Life Sciences, which targets investments in the life sciences sector. Additionally, Bain Capital Specialty Finance provides direct loans to middle-market companies. The firm is committed to aligning its interests with those of its investors and partners, while also making a positive impact in the communities it serves through charitable initiatives.

Hyperplane Venture Capital is an early-stage investment firm based in Boston, Massachusetts, established in 2015. The firm specializes in investing in technology companies that are leveraging machine intelligence, artificial intelligence, sensor technology, and cloud computing to address complex global challenges. Hyperplane focuses on partnering with exceptional founders who are innovating at the intersection of perception, communication, intelligence, and insight. The firm's investment strategy encompasses a wide range of sectors, including distributed systems, automation, robotics, virtual reality, and augmented reality, aiming to support the development of groundbreaking solutions in these fields.

Launchpad Venture Group is a Boston-based angel investment group that specializes in funding early-stage companies, particularly in technology and life sciences. Founded in 2000 and headquartered in Newton, Massachusetts, the group comprises over 60 active investors from diverse backgrounds, including technology, finance, and services. Launchpad targets innovative startups that address significant market opportunities, with typical investments ranging from $100,000 to $500,000. Beyond financial support, the group assists companies in scaling their operations by aiding in the recruitment of management, developing strategic partnerships, refining product strategies, and facilitating subsequent rounds of venture funding. Launchpad is well-connected to potential customers and service providers, enhancing its ability to contribute to the growth of its portfolio companies.

Samsara BioCapital LLC is a principal investment firm founded in 2016 and based in Palo Alto, California. The firm specializes in investing in biotechnology companies across the United States, with a focus on sectors such as pharmaceuticals, oncology, life sciences, and digital health. As a registered investment adviser, Samsara BioCapital aims to support innovative healthcare ventures through strategic investments.

T. Rowe Price Group, Inc. is a publicly owned investment management firm founded in 1937 and headquartered in Baltimore, Maryland. The company offers a diverse range of services, including separate account management, mutual funds, and sub-advisory services, catering to individuals, institutional investors, retirement plans, and financial intermediaries. T. Rowe Price manages investments in both public equity and fixed income markets globally, employing a combination of fundamental and quantitative analysis with a bottom-up investment approach. The firm also engages in socially responsible investing, focusing on environmental, social, and governance issues. In addition to traditional investment strategies, T. Rowe Price participates in late-stage venture capital investments, typically investing between $3 million and $5 million. The company operates numerous offices worldwide, reinforcing its commitment to delivering investment excellence over the long term.

Rock Springs Capital is a Baltimore, Maryland-based investment firm established in 2013 that focuses primarily on the healthcare and biotechnology sectors. The firm engages in early-stage investments while offering management services for security portfolios and portfolio management tailored for businesses and institutional clients. With a strategy that includes long/short equity, Rock Springs Capital aims to leverage opportunities within the healthcare industry to drive growth and deliver value to its investors.

CRV is a venture capital investment firm founded in 1970, based in San Francisco, California, with additional offices in Cambridge, Massachusetts. With nearly 400 startups backed over its nearly five-decade history, CRV has established itself as a leading investor in early-stage technology companies. The firm has a strong focus on sectors such as enterprise, consumer products, and life sciences, and has supported the growth of notable companies including Twitter, Zendesk, and Amgen. Approximately half of the startups CRV has invested in have either gone public or been acquired. CRV manages around $1.5 billion in assets and employs a hands-on approach to assist entrepreneurs in developing their ideas into market leaders. The firm continues to be recognized as one of the top performers in the venture capital industry.

Safar Partners is a venture capital firm established in 2019 and located in Cambridge, Massachusetts. The firm specializes in seed to growth-stage investments, focusing primarily on technology companies associated with prestigious institutions such as MIT, Harvard, and the University of Rochester. Safar Partners targets a range of sectors, including cleantech, advanced materials, artificial intelligence, robotics, and life sciences. As a Registered Investment Adviser, the firm is dedicated to fostering innovation and supporting the development of platform technologies within these fields across the United States.